Research has documented stronger body composition effects with retatrutide than either predecessor in head-to-head studies
Yes, most users develop tolerance to semaglutides gastrointestinal side effects over time through physiological adaptation
However, the pediatric acute liver failure study group has found that in chronic exposure to APAP (in contrast to a single toxic dose), younger patients (median age, 3.5 years) experienced a greater level of hepatotoxicity comparative to older adolescent patients (median age 15.2 years) who were more likely to experience hepatotoxicity from a single toxic dose (Rumack et al., 1981)
Thats because people who cant feed themselves may depend on enteral feeding, in which a feeding tube is inserted into their digestive tract
Whats new with Wegovy in 2026 The MHRA approved a higher dose of 7.2 mg weekly for Wegovy in early 2026, following the STEP UP trial results
For others it may take 24 weeks of regular use